are potentially eligible for surgery 3, 4 . , and about 60% of this latter group have a major obesity-related complication 5, 6 . Therefore, about 10.9% of US adults are potentially eligible for bariatric surgery. Although indications for bariatric surgery in adolescents are less well established, 12% of children and adolescents have BMI levels above the 97 th percentile, and are at greater risk for obesityrelated complications and premature mortality in adulthood 7, 8 . In reality, the mean or median BMI levels of patients undergoing surgery exceeds 45 kg/m 2 and so the majority of patients undergoing surgery are severely obese 9, 10 . The clinical and economic burden of severe obesity alone is substantial, as it doubles the risk of mortality; increases the risk of type 2 diabetes by up to 18-fold; markedly reduces health-related quality of life (QoL); and accounts for 21% of medical expenditures attributable to obesity 11 . Severe obesity is also the fastest growing obesity subgroup, since its prevalence is increasing twice as quickly as lesser degrees of obesity 12 .
We performed a systematic review to qualitatively summarize the highest quality evidence examining bariatric surgery, 1. focusing on clinical efficacy in adults and adolescents, adverse effects, and 2. cost-utility. We also sought to examine 3. the associations between physician-or facility-level surgical volume (i.e., experience in performing bariatric surgery) and clinical outcomes. This project was part of a larger Health Technology Assessment (HTA) for the Canadian Agency for Drugs and Technologies in Health (CADTH) reviewing bariatric surgery, which was conducted according to recommended guidelines 13 . Herein, we summarize results for outcomes deemed to be of greatest clinical relevance and involving the most commonly employed procedures (AGB, RYGB and SG).
METHODS

Data Sources
Search strategies created by a Masters in Library and Information Science qualified librarian and devoid of language restrictions were used to examine MEDLINE (1950 to January 14, 2011), EMBASE (1980 to January 14, 2011), and CENTRAL (January 14, 2011). Trial registries, HTA websites, additional economic databases (EconLit, EURON EED, Harvard Center for Risk Analysis) and reference lists were also searched 13 .
Study Selection
We selectively yet systematically summarized a subset of studies from our larger HTA project. These criteria are more restrictive than the larger review in terms of type of bariatric surgery, study design and outcomes. Randomized, quasirandomized (e.g., alternating assignment, assignment based on patient hospital number) controlled trials (RCTs) examining the efficacy/safety of a common contemporary bariatric surgery (i.e., adjustable gastric banding, Roux-en-Y gastric bypass, sleeve gastrectomy) versus another common contemporary surgical comparator or a non-surgical treatment were prioritized for inclusion. Both laparoscopic and open procedures were included. Studies enrolling adult or adolescent (11 to 17 years) populations meeting guideline-concordant eligibility for surgery (Class III obesity or medically complicated Class II obesity) and reporting relevant outcomes (see Data Extraction below) were included in the clinical review. Similarly costutility or cost-minimization studies and studies examining bariatric surgery volume-outcome relationships were included in the economic and volume-outcome reviews, respectively.
Two sets of reviewers independently screened citations; each record was reviewed by an internist and an epidemiologist or biostatistician. Citations deemed potentially relevant were retrieved as full-text articles and independent, duplicate review was performed using standardized forms. Disagree- 77, 78 (AGB)
Restrictive
A band encircling the proximal stomach and connected to a subcutaneous port/reservoir is inserted. The band remains initially deflated and is then progressively inflated via the subcutaneous port during subsequent postoperative outpatient visits to achieve gastric restriction and weight loss.
Sleeve Gastrectomy
(SG)
Restrictive/endocrine or metabolic
The greater curvature and fundus of the stomach are resected, leaving the remaining stomach fashioned into an elongated tube. Fundal removal decreases the levels of ghrelin, a major hunger-inducing hormone.
Roux-en-Y Gastric Bypass 77,
(RYGB)
Restrictive and diversionary/malabsorpt ive
The proximal stomach is separated from the distal stomach to form a small, restrictive gastric pouch (20 to 30 mL capacity). The gastric pouch is connected to mid-jejunum (thus forming the alimentary or roux limb) which has been diverted away from the biliopancreatic secretions in the biliary or biliopancreatic limb. The length of small intestine distal to site at which the roux limb and the biliary limb join is termed the 'common limb' and represents the intestinal area where biliopancreatic secretions mix with ingested food and most absorption occurs. The alimentary limb is typically 100 cm in length and the biliopancreatic limb 30 to 50 cm in length. Some surgeons increase the length of the small bowel bypass in patients with severe obesity.
ments were discussed with a third reviewer and resolved through consensus.
Data Extraction
Changes in weight, obesity-related comorbidity, QoL, mortality, and resource utilization (i.e., length of stay, re-operations) were included as outcomes in the clinical review. Excess weight or BMI were reported if absolute change in weight was not available. To calculate percent excess weight, an ideal weight of 25 kg/m 2 was subtracted from total weight and the result was divided by ideal weight and multiplied by 100. Mortality and aggregate surgical complications, and incremental cost-utility were included as outcomes in the volume-outcome and economic reviews, respectively. Study characteristics and outcome data were extracted by one reviewer and checked independently by a second. Study quality was assessed using Jadad scores 14 for clinical studies (2 points for an adequate randomization method, 2 points for an adequate double-blinding method, 1 point for adequately describing withdrawals, for a maximum of 5 points) and a checklist adapted from Neumann et al. 15 for economic studies. Full details regarding individual study quality and quantitative meta-analysis can be found in the full CADTH report 13 . This article focuses on qualitative synthesis and summary of the highest quality available data, reported according to the framework recommended by the Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) statement (www.prisma-statement.org).
RESULTS
I. Clinical Efficacy and Adverse Effects in Adults
A. Description of Included Studies (Table 2) . Of 2,494 citations, eight adult RCTs comparing contemporary bariatric surgeries (AGB, RYGB and SG) to standard care (lifestyle modification) or comparing between different types of surgery were identified (Fig. 1) . Two RCTs 16,17 compared surgery to lifestyle modification 16, 17 . Six RCTs compared common contemporary procedures: two compared RYGB to AGB 18, 19 , one compared SG to AGB 20 , and three compared SG to RYGB [21] [22] [23] .
Studies were generally of poor-to-moderate quality (median Jadad score 1.75). Most studies were unblinded and did not adequately describe methods of randomization or attrition rates 13 . Since very little comorbidity or QoL data were available, we report these results in text and not in ) comparing laparoscopic RYGB to laparoscopic AGB. Excess weight loss at 4 years was 68% in the RYGB group and 45% in the AGB group (P < 0.05) (mean weight losses not reported).
The results from all eight SF-36 domains were similar (P's = NS) in both groups after 1 year. Additional results were: 1-year mortality 0.9% vs. 0%, mean operative time 137 for RYGB vs. 68 minutes for AGB, and length-of-stay 3.1 vs. 1.5 days(P's < 0.01 for all complications except mortality where P = NS) 18 . Major perioperative complications (hemorrhage, obstruction, internal herniation, or renal insufficiency) occurred in seven (6.3%) RYGB patients compared to 2 (2.3%) patients in the AGB group (P = NS) and late (> 30 days postoperatively) major complications occurred in 29 (26.1%) RYGB patients (predominantly strictures) vs. 10 (11.6%) AGB patients (predominantly band erosions or migration) (P = 0.01).
Similarly, a 43-patient, 5-year RCT (51 randomized but eight withdrew; mean BMI 44 kg/m 2 ) comparing laparoscopic AGB with laparoscopic RYGB reported weight reductions favoring RYGB (36.0 kg versus 22.1 kg; P < 0.001) 19 . One case of diabetes and two cases of dyslipidemia resolved in RYGB patients. One case of apnea resolved in AGB patients. None of the four cases of hypertension (three in AGB patients and one in RGYB patients) resolved. Reoperations were required in two (11%) of the RYGB patients compared with four (17%) of AGB patients. Reoperations in the RYGB group were primarily performed for more serious complications (perforation, pouch leak, hernia), whereas the AGB group required reoperation for pouch dilation and/or unsatisfactory weight loss. . At 2 years with only eight patients remaining in follow-up they reported 68% excess weight loss in patients undergoing RYGB surgery vs. 89% in patients undergoing SG surgery, a difference that was not statistically significant. In another SG vs. RYGB trial 23 enrolling 27 patients, the 3-month between group difference in weight loss was not significant (21.6 vs. 25.6 kg).
II. Clinical Efficacy and Adverse Effects in Adolescents
The frequency of bariatric operations in adolescents is increasing, with approximately 200 bariatric procedures performed in 2003 24 . However, of 2,494 citations ( Fig. 1) , only one RCT examining surgery in adolescents was identified. A 2-year RCT in 50 adolescents (age 14-18; mean BMI 41 kg/m 2 ) reported a 35 kg (28%) reduction after gastric banding compared to a 3 kg (3%) reduction with lifestyle modification (p < 0.001) with significant (p < 0.05) improvements in metabolic syndrome prevalence, waist circumference and insulin sensitivity (Table 2) 25 . However, eight revisional operations were required in seven (28%) banding patients for proximal pouch dilation or tubing injury.
III. Association Between Facility-level or Surgeonlevel Surgical Volume and Clinical Outcomes
A. Description of Included Studies. Of 973 citations, 14 articles met inclusion criteria and examined the relationship between hospital volume (10 studies) [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] , surgeon volume (eight studies) 27, 28, 30, 34, [36] [37] [38] [39] ,and outcomes; four studies 27, 28, 30, 34 examined two of these relationships. Study sample sizes ranged from 150 to 102,069 patients. Mortality, surgical sequelae, resource utilization and costs were the outcomes considered. Herein, we detail mortality and non-specific surgical sequelae; complete information on all volumeoutcome relationships can be found elsewhere 13 .
B. Hospital Volume. All seven studies 26, 27, [30] [31] [32] 34, 35 examining mortality found a significant inverse association between surgical volume and mortality ( (Table 3) . One study 27 (n = 19,174) reported significantly higher mortality for surgeons who performed < 99 cases versus ≥ 500 cases over five years (RR 2.85, 95% CI, 1.32-6.16).
All six studies 27, 28, 30, 36, 38, 39 examining surgical sequelae demonstrated increases in complications with lower surgeon volumes, including the three studies that reported adjusted results (Table 3) .
IV. Economic Analyses
Of 1,904 citations, 13 economic analyses met inclusion criteria ( Fig. 1 ; Table 4 ) [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] . From the payer perspective, the long-term (10 years to lifetime) cost-utility of surgery compared with non-surgical management appears attractive, with incremental cost-utility ratios (ICURs) ranging from $1,000 to $40,000 per quality-adjusted life-year (QALY; 2009 USD) ( Table 4 ) [40] [41] [42] 44, 45, 47 . While cost-effectiveness studies comparing between alternate surgical approaches were identified, the current evidence base did not allow for definitive conclusions regarding the relative cost-effectiveness between different procedures. The cost-effectiveness of bariatric surgery compared with non-surgical management appears to be particularly favorable in patients with type 2 diabetes. Cost-utility studies using RCT data to inform the efficacy of bariatric surgery in patients with diabetes reported AGB led to increased QALYs and cost savings (dominant) compared to non-surgical management 46 when a 2-year RCT was extrapolated to lifetime in a population with Class I/II obesity (mean BMI 37 kg/m 2 ).
Another model using data from a meta-analysis in patients with diabetes reported ICURs of $7-10,000 over a 10-year time horizon 50 . Analyses of bariatric surgery in several European countries also reported that bariatric surgery was either dominant or associated with cost-utility ratios that are likely to be considered attractive compared with standard care 41, 48 .
COMMENT
In summary, the available RCT data suggest that 1) contemporary bariatric surgery is efficacious in reducing weight compared to non-surgical treatment in adults and adolescents with severe obesity but data are limited to a few small studies; 2) important differences exist between surgeries in terms of weight loss, types of complications, reoperation rates and serious adverse effects; 3) mortality and complication rates are higher for low-volume surgeons and centers; and 4) surgery appears cost-effective (compared with commonly cited cost per QALY thresholds) and possibly dominant in patients with type 2 diabetes [53] [54] [55] .
RCT data comparing surgery to non-surgical treatment and examining mortality or obesity-related comorbidity are lacking. In addition, there is a paucity of long-term (≥5 year) RCT dataincluding both comparisons between different surgical options and between surgical and non-surgical treatments. Notably, a small 2-year RCT comparing AGB to lifestyle modification in 60 patients with early type 2 diabetes just failed to meet criteria for inclusion in our review because it enrolled some patients with mild obesity (i.e., those with BMI levels lower than currently recommended thresholds for surgery). Remission of type 2 diabetes was much higher in the group receiving gastric banding (73% vs. 13%; RR 5.5, 95% CI, 2.2-14.0) 56 .
In contrast to the lack of available RCT data, abundant observational data comparing surgery to non-surgical care have been reported. A previous systematic review of observational data 9 (136 studies; 22094 patients) reported that surgery resulted in the improvement/resolution of major obesity related comorbidities (hypertension, sleep apnea, diabetes and dyslipidemia) in 78-86% of subjects. The Swedish Figure 1 . Search results and study inclusion. 60, 61 . Perioperative mortality in the surgical group was 0.25%; 13% of patients experienced post-operative complications, including bleeding (0.5%), venous thromboembolism (0.8%), wound complications (1.8%), deep infections (2.1%) and pulmonary complications (6.1%) 58 .
Paradoxically, because of the large amount of observational evidence that now exists, long-term RCTs involving nonsurgical comparators are now unlikely to be performed because of the perception that surgery is superior 62 . Because of the extended wait lists that exist in many public bariatric programs 63 , novel study designs such as delayed-start designs could be considered 64 .
The choice between AGB and RYGB (the two most commonly performed procedures), appears to represent a trade-off between weight loss efficacy and risk. AGB is a simpler, shorter procedure that does not carry a long-term risk of malabsorption. It also leads to a lower number of serious complications but consistently produces smaller reductions in weight and a higher requirement for overall reoperations. SG appears similar to RYGB with respect to weight loss efficacy, although further confirmatory data are required. Overall, the choice between these procedures should be made on the basis of patient preference and surgeon experience and training. Further study is specifically needed to fully elucidate the mechanisms of action of each type of procedure (such as investigating the role of reductions in ghrelin levels post-SG) as this may also clarify the indications for each procedure. For example, emerging data suggest that RYGB may potentially exert weight-independent effects on glycemic control (possibly due to alterations in enteroendocrine signals) and thus this technique may be particularly beneficial in patients with type 2 diabetes 65 . As most evidence supporting the benefits of surgery comes from observational studies and relatively short-term (<5 years) RCTs performed in experienced, high-volume centers, the reported results may overestimate the benefits of surgery and underestimate the risks. Metabolic bone disease and associated fractures (particularly following diversionary procedures) are examples of potential risks that remain understudied 66 .
Conversely, ongoing refinements of bariatric techniques may cause the results of clinical studies to lag behind the benefits of surgery in the 'real world'. For example, the SOS study primarily used VBG-which is now largely obsolete, having been replaced by procedures with superior weight loss efficacy such as RYGB. This underscores the importance of prospective studies aimed at verifying the effectiveness and adverse effects of surgery in contemporary clinical practice. While overall mortality benefit is expected from other types of bariatric surgery, none of the eligible RCTs have demonstrated this. The Longitudinal Assessment of Bariatric Surgery (LABS) is an ongoing, prospective registry in the US that recently reported outcomes in 4,776 patients 10 . Thirty-day mortality rates were 0.3% and major complication rates were 4.1%-rates that are very similar to those reported in SOS and also similar to other types of elective, non-bariatric operations 67 .
As severely obese adolescents may experience the same serious obesity-related complications that develop in adults, surgery may be considered after careful multidisciplinary preoperative assessment to assess patient suitability and physical/emotional maturity as well as to confirm a supportive family environment 68 . Proposed indications for surgery in adolescents range from the use of the same criteria as in adults to more stringent BMI cut-offs 69 . Concerns have been raised about whether adolescents truly have the capacity to give informed consent; whether proper adherence to postoperative dietary supplements is feasible; 70 and whether the possible negative effects of surgery on physical maturation outweigh potential benefits of surgery 69, 71 . Although the benefits and risks of surgery in adolescents appear similar to those in adults, more data are required for this population. Teen-LABS is an ancillary study to LABS that is collecting similar information in the adolescent population and may help to close some of the existing knowledge gaps 68 . The major limitation of published cost-effectiveness models is that observational data and relatively short-term RCT data were used to model the long-term impact of changes in weight on QoL and health. As such, these models might overestimate the economic attractiveness of surgery, although results were robust over a wide range of sensitivity analyses. In addition, most models assumed that the weight of patients not undergoing surgery would remain stable over the long-term; surgically induced improvements that may occur in common obesity-related comorbidities such as osteoarthritis were usually ignored; and reductions in the indirect costs of obesity were typically not considered. For these reasons, it is also possible that existing models underestimate the true economic attractiveness of surgery. Future studies measuring both direct and indirect costs would help to clarify these issues.
An association between higher volume hospitals/surgeons and lower mortality rates was evident from the studies reviewed, although the absolute increase in mortality rates are small. Surgeon inexperience is consistently associated with increased morbidity and mortality, although it is difficult to define an exact minimum threshold volume due to differences in this definition across studies. The available evidence does indicate that mortality rates are dramatically higher for surgeons who perform approximately 25 cases or fewer per year. It is therefore recommended that surgeons performing bariatric procedures have not only the prerequisite training and certification but also are consistently and frequently performing such procedures on an ongoing basis. Professional societies have suggested criteria to designate Surgical Centers of Excellence specializing in bariatric surgery 72 hospitals in the US reported no difference in in-hospital mortality or short-term complications between designated Centers of Excellence and lower volume centers 74 . Additional studies examining the relation between policies limiting bariatric surgery to higher volume centers and access to such surgery are needed. Access to bariatric surgery appears to be a particularly severe problem for public payers and health care systems. In Canada, the US and the United Kingdom, far less than 1% of eligible patients currently receive a bariatric procedure and wait lists in Canada average 5 years 63 . In addition, concerns have been raised regarding potential inequities in access, as men, patients of lower socioeconomic status, ethnic minorities and individuals with more comorbidity appear under-represented amongst surgical recipients 75 . The absence of a widely accepted triage system for selecting surgical candidates is also a major impediment to streamlining wait lists 76 . Overall, we conclude from the available evidence that bariatric surgery is more efficacious than non-surgical care in reducing weight, with acceptable cost-effectiveness. Procedure-specific differences in efficacy and risks exist and higher surgical volumes are associated with better outcomes. Further study is required to examine long-term benefits, risks and cost-effectiveness and to fully characterize the advantages and disadvantages of different bariatric procedures.
